Author | Jeff Sharman, MD | OncLive

Author | Jeff Sharman, MD

Articles

Dr. Sharman on Remaining Challenges With BTK Inhibitors in CLL

February 07, 2020

Video

Jeff Sharman, MD, discusses the question of BTK inhibitors in treating patients with chronic lymphocytic leukemia.

Dr. Sharman on the Design of the ELEVATE-TN Trial in CLL

January 22, 2020

Video

Jeff Sharman, MD, discusses the design of the phase III ELEVATE-TN trial in patients with previously untreated chronic lymphocytic leukemia.

Dr. Sharman on the Potential Future of Acalabrutinib in CLL

August 12, 2019

Video

Jeff Sharman, MD, director of research at Willamette Valley Cancer Institute and medical director of hematology research for The US Oncology Network, discusses the potential future of acalabrutinib (Calquence) in chronic lymphocytic leukemia (CLL).

Dr. Sharman on the Phase III Results of the GENUINE Study in CLL

June 05, 2017

Video

Jeff Sharman, MD, medical director, Hematology Research, The US Oncology Network, discusses the phase III findings of the GENUINE study, the combination of ublituximab (TG-1101) and ibrutinib (Imbruvica) for patients with previously treated high-risk chronic lymphocytic leukemia (CLL).

x